In support of this hypothesis, treatment with dexamethasone counteracted cholestasis-related hepatic inflammation by preventing NFκB translocation to the nucleus and restored TNFα, IL-6, and IL-1β mRNA levels in the liver of cholestatic rats [62]. This evidence concerns the gene IL1B and cholestasis.